Development and Characterization of Lyophilized Extracellular Vesicles (EVs) for Enhanced Stability and Cellular Repair

Extracellular vesicles (EVs), particularly exosomes, are nanoscale vesicles that are secreted by all cell types and play critical roles in intercellular communication. They have emerged as promising candidates for both diagnostic and therapeutic applications in a wide range of diseases, including cancer, neurodegenerative disorders, and inflammatory conditions. Despite their broad research and translational potential, widespread implementation of EV-based products is hindered by the need for ultra-low temperature storage (−80°C), which complicates logistics, limits accessibility, and increases operational costs.

Lyophilization, or freeze-drying, presents a viable solution by enabling the development of stable, room-temperature formulations. This method removes water from EV preparations under low pressure and temperature, preserving their structural and functional integrity. By eliminating the need for cold-chain logistics, lyophilization could significantly enhance the scalability, accessibility, and global distribution of EV-based products. 

However, the success of this approach depends on the careful selection of buffer systems and cryoprotectants that can protect the biophysical and functional properties of EVs during the drying and rehydration processes. Cryoprotectants such as sugars, polymers, and amino acids can stabilize the lipid bilayer and protein components of EVs, preventing aggregation or degradation. Understanding the interplay between these components is essential for developing a robust lyophilized EV platform suitable for clinical and commercial applications.